NEW YORK, Feb. 08, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced a collaboration with actress Christina Applegate to help raise awareness of multiple sclerosis (MS) and ...

Somiya Adrees is a writer at GameRant. Her gaming journey began at a young age with classics like Super Mario Bros., Sonic the Hedgehog, and Disney's Aladdin in Nasira's Revenge (all of which she ...

As 2024 begins drawing to a close, it’s time to look ahead at Netflix’s new animated series slate. Below, we’ll cover all the new and returning animated shows expected to hit our screens in 2025 and ...

TG Therapeutics continues strong execution with Briumvi, maintaining beat-and-raise performance and robust financials, including a new $100 million buyback program. However, high investor expectations ...

Greetings, and welcome to the TG Therapeutics' Third Quarter Earnings Call and Webcast. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to ...

Netflix‘s Indonesian horror film “The Elixir” has surged to the top of the streamer’s worldwide rankings for non-English language titles, drawing more than 11 million viewers in the first several days ...

I am, for the most part, kind of over zombie movies. As much as I enjoyed 28 Days Later and inhaled the early seasons of The Walking Dead, the genre is a bit played out at this point. (Even the highly ...

Fast zombies x slow people = carnage is the formula for The Elixir (now streaming on Netflix), a new blood ‘n’ guts outing from prolific Indonesian director Kimo Stamboel. And by “slow” I mean “slow ...

Jeff Kmiotek, Michael Zinman and Andrew Watnick have been in unscripted TV production for decades. Kmiotek became a producer after working in a variety of unscripted formats including game and cooking ...

Taylor Pittman got her Technical and Creative Writing Degree in 2021 and has a passion for video games and storytelling. She has enjoyed reading and writing since she was old enough to pick up a ...

A huge miss on the bottom line drove investors away from the shares. Yet sales of the company's one commercialized medicine have been brisk. The company, best known for its multiple sclerosis (MS) ...